PACB Stock Falls on Preliminary Q4 Sales Miss, 7 Vega Systems Shipped

Pacific Biosciences of California, Inc. (PACB) , popularly known as PacBio, recently shared its preliminary results for the fourth quarter and full year of 2024. Shares of PacBio closed 8% down on Jan. 14, as the top line missed market expectations.The company is scheduled to release fourth-quarter results on Feb. 15, 2025.Q4 Preliminary ResultsPacBio reported preliminary revenues of $39.2 million, down 33$40.9 million.Consumable revenues are antic ...